Fig. 3: Summary of the differential gene expression (DGE) and pathway analyses between the ARNA × AHSCAE group and the ‘Others’ groups. | npj Precision Oncology

Fig. 3: Summary of the differential gene expression (DGE) and pathway analyses between the ARNA × AHSCAE group and the ‘Others’ groups.

From: Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis

Fig. 3

Volcano plot of the DGE analysis (a). Significantly enriched genes and pathways in the ARNA × AHSCAE group are in red, whereas those significantly downregulated are in blue. b Summary report of the most significantly enriched gene sets belonging to the HALLMARK of Cancer and the LM22 human immune cells collections; values on the right side of the bars correspond to the proportion of genes activated in the ‘Other’ groups. c Heatmap of the 162 activated and inhibited genes from the PAMr cross-validated discriminant signature of the ARNA × AHSCAE group versus the ‘Others’ groups. All P-values on the plots were adjusted according to the Benjamini–Hochberg procedure. FC fold change.

Back to article page